ArticleJournal of general internal medicine2025
The Exceptional Nature of Health Care as an Economic Good.
Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health care reform proposals often differ on the appropriate balance of free market incentives versus government involvement. Often neglected is a basic question: is health care, desirable and scarce, similar to other economic goods? This perspective describes eight characteristics inherent in health care that make it exceptional as an economic good, not only in the USA but also in other rich countries. These are the following: disparity in knowledge between patient and provider; disparity in negotiating power; poorly defined "goods"; insurers acting as purchasers for patients; skewed concentration of expenses across individuals; the magnitude of costs and consequences; limits on the supply of health professionals; and an unavoidable moral dimension. The resulting complexity creates many opportunities to take financial advantage of patients. Even without taking advantage, market forces have predictable consequences, such as denying care to those unable to pay. While excesses traditionally have been constrained by professional ethics, concerns are growing that monetizing medicine has gone too far. Addressing these concerns with greater government involvement brings its own issues, however. Intervention can be inflexible, political, legalistic, costly, and one size fits none. Market forces can also work well when products and services are well defined, information sources are good, purchasers have time to choose carefully, and barriers to entry are modest. Health policy is hard because the right balance between free markets and government involvement is elusive. Anyone advocating changes to markets - one way or the other - must take into account the exceptional nature of health care as an economic good.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.